197067530	197067530	CD	B-NP	O
|	|	NN	I-NP	O
LCH	LCH	NN	I-NP	O
|	|	NN	I-NP	O
20930664	20930664	CD	I-NP	O
|	|	NN	I-NP	O
|	|	NN	I-NP	O
674942	674942	CD	B-NP	O
|	|	CC	I-NP	O
11/23/2000	11/23/2000	CD	I-NP	O
12	12	CD	I-NP	O
:	:	:	O	O
00	00	CD	B-NP	O
:	:	:	O	O
00	00	CD	B-NP	O
AM	AM	VBP	B-VP	O
|	|	JJ	B-NP	B-protein
Syncope	Syncope	NNP	I-NP	I-protein
|	|	NNP	I-NP	I-protein
|	|	NNP	I-NP	I-protein
DIS	DIS	NNP	I-NP	I-protein
|	|	NNP	I-NP	I-protein
Admission	Admission	NNP	I-NP	O
Date	Date	NNP	I-NP	O
:	:	:	O	O
8/6/2000	8/6/2000	CD	B-NP	O
Report	Report	NNP	I-NP	O
Status	Status	NNP	I-NP	O
:	:	:	O	O
Discharge	Discharge	NNP	B-NP	O
Date	Date	NNP	I-NP	O
:	:	:	O	O
9/14/2000	9/14/2000	CD	B-NP	O
******	******	SYM	I-NP	O
DISCHARGE	DISCHARGE	NN	I-NP	O
ORDERS	ORDERS	NN	I-NP	O
******	******	SYM	B-VP	O
KOMLOS	KOMLOS	NN	B-NP	O
,	,	,	O	O
COLEMAN	COLEMAN	NN	B-NP	O
657-85-93-4	657-85-93-4	CD	I-NP	O
Rieville	Rieville	NNP	I-NP	O
Service	Service	NNP	I-NP	O
:	:	:	O	O
MED	MED	NNP	B-NP	O
DISCHARGE	DISCHARGE	NNP	I-NP	O
PATIENT	PATIENT	NNP	I-NP	O
ON	ON	NNP	I-NP	O
:	:	:	O	O
8/11	8/11	CD	B-NP	O
AT	AT	NN	I-NP	O
04	04	CD	I-NP	O
:	:	:	O	O
00	00	CD	B-NP	O
PM	PM	NN	I-NP	O
CONTINGENT	CONTINGENT	NN	I-NP	O
UPON	UPON	NN	I-NP	O
HO	HO	NN	I-NP	O
evaluation	evaluation	NN	I-NP	O
WILL	WILL	MD	B-VP	O
D/C	D/C	NNP	B-NP	O
ORDER	ORDER	NNP	I-NP	O
BE	BE	NNP	I-NP	O
USED	USED	NNP	I-NP	O
AS	AS	NNP	I-NP	O
THE	THE	NNP	I-NP	O
D/C	D/C	NNP	I-NP	O
SUMMARY	SUMMARY	NNP	I-NP	O
:	:	:	O	O
YES	YES	NNP	B-NP	O
Attending	Attending	NNP	I-NP	O
:	:	:	O	O
DELFELDER	DELFELDER	NNP	B-NP	O
,	,	,	O	O
MILLARD	MILLARD	NNP	B-NP	O
L.	L.	NNP	I-NP	O
,	,	,	O	O
M.D.	M.D.	NNP	B-NP	O
CODE	CODE	NNP	I-NP	O
STATUS	STATUS	NNP	I-NP	O
:	:	:	O	O
Full	Full	JJ	B-NP	O
code	code	NN	I-NP	O
DISPOSITION	DISPOSITION	NN	I-NP	O
:	:	:	O	O
Home	Home	NN	B-NP	O
w	w	NN	I-NP	O
/	/	SYM	B-NP	O
services	service	NNS	I-NP	O
DISCHARGE	DISCHARGE	NN	I-NP	O
MEDICATIONS	MEDICATIONS	NNS	I-NP	O
:	:	:	O	O
TYLENOL	TYLENOL	NN	B-NP	O
-LRB-	-LRB-	NN	I-NP	O
ACETAMINOPHEN	ACETAMINOPHEN	NN	I-NP	O
-RRB-	-RRB-	NN	I-NP	O
650-1	650-1	CD	I-NP	O
,	,	,	I-NP	O
000	000	CD	I-NP	O
MG	MG	NN	I-NP	O
PO	PO	NN	I-NP	O
Q4H	Q4H	NN	I-NP	O
PRN	PRN	NN	I-NP	O
pain	pain	NN	I-NP	O
AMIODARONE	AMIODARONE	NN	I-NP	O
200	200	CD	I-NP	O
MG	MG	NNP	I-NP	O
PO	PO	NNP	I-NP	O
QD	QD	NNP	I-NP	O
Override	Override	NNP	I-NP	O
Notice	Notice	NNP	I-NP	O
:	:	:	O	O
Override	Override	NNP	B-NP	O
added	add	VBD	B-VP	O
on	on	IN	B-PP	O
7/19	7/19	CD	B-NP	O
by	by	IN	B-PP	O
KNIGHTSTEP	KNIGHTSTEP	NNP	B-NP	O
,	,	,	O	O
HAYDEN	HAYDEN	NNP	B-NP	O
S.	S.	NNP	I-NP	O
on	on	IN	B-PP	O
order	order	NN	B-NP	O
for	for	IN	B-PP	O
COUMADIN	COUMADIN	NN	B-NP	O
PO	PO	NN	I-NP	O
-LRB-	-LRB-	NN	I-NP	O
ref	ref	NN	I-NP	O
#	#	#	B-NP	O
90894077	90894077	CD	I-NP	O
-RRB-	-RRB-	NNP	I-NP	O
POTENTIALLY	POTENTIALLY	NNP	I-NP	O
SERIOUS	SERIOUS	NNP	I-NP	O
INTERACTION	INTERACTION	NNP	I-NP	O
:	:	:	O	O
AMIODARONE	AMIODARONE	NNP	B-NP	O
HCL	HCL	NNP	I-NP	O
&	&	CC	I-NP	O
WARFARIN	WARFARIN	NNP	I-NP	O
Reason	Reason	NNP	I-NP	O
for	for	IN	B-PP	O
override	override	NN	B-NP	O
:	:	:	O	O
md	md	NN	B-NP	O
aware	aware	JJ	I-NP	O
Previous	Previous	JJ	I-NP	O
override	override	NN	I-NP	O
information	information	NN	I-NP	O
:	:	:	O	O
Override	Override	NN	B-NP	O
added	add	VBN	B-VP	O
on	on	IN	B-PP	O
7/5	7/5	CD	B-NP	O
by	by	IN	B-PP	O
SCRUDATO	SCRUDATO	NNP	B-NP	O
,	,	,	O	O
DWAYNE	DWAYNE	NNP	B-NP	O
MYLES	MYLES	NNP	I-NP	O
,	,	,	O	O
M.D.	M.D.	NNP	B-NP	O
on	on	IN	B-PP	O
order	order	NN	B-NP	O
for	for	IN	B-PP	O
COUMADIN	COUMADIN	NNP	B-NP	O
PO	PO	NNP	I-NP	O
VARIABLE	VARIABLE	NNP	I-NP	O
-LRB-	-LRB-	NNP	I-NP	O
ref	ref	NN	I-NP	O
#	#	#	B-NP	O
58360062	58360062	CD	I-NP	O
-RRB-	-RRB-	NNP	I-NP	O
POTENTIALLY	POTENTIALLY	NNP	I-NP	O
SERIOUS	SERIOUS	NNP	I-NP	O
INTERACTION	INTERACTION	NNP	I-NP	O
:	:	:	O	O
AMIODARONE	AMIODARONE	NNP	B-NP	O
HCL	HCL	NNP	I-NP	O
&	&	CC	I-NP	O
WARFARIN	WARFARIN	NNP	I-NP	O
Reason	Reason	NNP	I-NP	O
for	for	IN	B-PP	O
override	override	NN	B-NP	O
:	:	:	O	O
tolerates	tolerate	VBZ	B-VP	O
Previous	Previous	JJ	B-NP	O
override	override	NN	I-NP	O
information	information	NN	I-NP	O
:	:	:	O	O
Override	Override	NN	B-NP	O
added	add	VBN	B-VP	O
on	on	IN	B-PP	O
7/5	7/5	CD	B-NP	O
by	by	IN	B-PP	O
RECHEL	RECHEL	NNP	B-NP	O
,	,	,	O	O
JOSH	JOSH	NNP	B-NP	O
AVERY	AVERY	NNP	I-NP	O
,	,	,	O	O
M.D.	M.D.	NNP	B-NP	O
POTENTIALLY	POTENTIALLY	NNP	I-NP	O
SERIOUS	SERIOUS	NNP	I-NP	O
INTERACTION	INTERACTION	NNP	I-NP	O
:	:	:	O	O
WARFARIN	WARFARIN	NNP	B-NP	O
&	&	CC	I-NP	O
AMIODARONE	AMIODARONE	NNP	I-NP	O
HCL	HCL	NN	I-NP	O
Reason	Reason	NNP	I-NP	O
for	for	IN	B-PP	O
override	override	NN	B-NP	O
:	:	:	O	O
tolerates	tolerate	VBZ	B-VP	O
Previous	Previous	NNP	B-NP	O
Alert	Alert	NNP	I-NP	O
overridden	overridden	JJ	I-NP	O
Override	Override	NNP	I-NP	O
added	add	VBD	B-VP	O
on	on	IN	B-PP	O
7/5	7/5	CD	B-NP	O
by	by	IN	B-PP	O
FURNAS	FURNAS	NNP	B-NP	O
,	,	,	O	O
CLAUD	CLAUD	NNP	B-NP	O
PHIL	PHIL	NNP	I-NP	O
,	,	,	O	O
M.D.	M.D.	NNP	B-NP	O
POTENTIALLY	POTENTIALLY	NNP	I-NP	O
SERIOUS	SERIOUS	NNP	I-NP	O
INTERACTION	INTERACTION	NNP	I-NP	O
:	:	:	O	O
WARFARIN	WARFARIN	NNP	B-NP	O
&	&	CC	I-NP	O
AMIODARONE	AMIODARONE	NNP	I-NP	O
HCL	HCL	NN	I-NP	O
Reason	Reason	NNP	I-NP	O
for	for	IN	B-PP	O
override	override	NN	B-NP	O
:	:	:	O	O
tolerates/monitored	tolerates/monitore	VBN	B-NP	O
COLACE	COLACE	NN	I-NP	O
-LRB-	-LRB-	NNP	I-NP	O
DOCUSATE	DOCUSATE	NNP	I-NP	O
SODIUM	SODIUM	NNP	I-NP	O
-RRB-	-RRB-	NNP	I-NP	O
100	100	CD	I-NP	O
MG	MG	NNP	I-NP	O
PO	PO	NNP	I-NP	O
BID	BID	NNP	I-NP	O
LASIX	LASIX	NNP	I-NP	O
-LRB-	-LRB-	NNP	I-NP	O
FUROSEMIDE	FUROSEMIDE	NNP	I-NP	O
-RRB-	-RRB-	NNP	I-NP	O
80	80	CD	I-NP	O
MG	MG	NNP	I-NP	O
PO	PO	NNP	I-NP	O
BID	BID	NNP	I-NP	O
Alert	Alert	NNP	I-NP	O
overridden	overridden	JJ	I-NP	O
:	:	:	O	O
Override	Override	NN	B-NP	O
added	add	VBN	B-VP	O
on	on	IN	B-PP	O
7/5	7/5	CD	B-NP	O
by	by	IN	B-PP	O
MCWHINNEY	MCWHINNEY	NNP	B-NP	O
,	,	,	O	O
VALENTINE	VALENTINE	NNP	B-NP	O
BUCK	BUCK	NNP	I-NP	O
,	,	,	O	O
M.D.	M.D.	NNP	B-NP	O
POSSIBLE	POSSIBLE	NNP	I-NP	O
ALLERGY	ALLERGY	NNP	I-NP	O
-LRB-	-LRB-	NNP	I-NP	O
OR	OR	NNP	I-NP	O
SENSITIVITY	SENSITIVITY	NNP	I-NP	O
-RRB-	-RRB-	NNP	I-NP	O
to	to	TO	B-PP	O
SULFA	SULFA	NNP	B-NP	O
Reason	Reason	NNP	I-NP	O
for	for	IN	B-PP	O
override	override	NN	B-NP	O
:	:	:	O	O
tolerates	tolerate	VBZ	B-VP	O
Previous	Previous	NNP	B-NP	O
Alert	Alert	NNP	I-NP	O
overridden	overridden	JJ	I-NP	O
Override	Override	NNP	I-NP	O
added	add	VBD	B-VP	O
on	on	IN	B-PP	O
7/5	7/5	CD	B-NP	O
by	by	IN	B-PP	O
GOLA	GOLA	NNP	B-NP	O
,	,	,	O	O
TODD	TODD	NNP	B-NP	O
AARON	AARON	NNP	I-NP	O
,	,	,	O	O
M.D.	M.D.	NNP	B-NP	O
POSSIBLE	POSSIBLE	NNP	I-NP	O
ALLERGY	ALLERGY	NNP	I-NP	O
-LRB-	-LRB-	NNP	I-NP	O
OR	OR	NNP	I-NP	O
SENSITIVITY	SENSITIVITY	NNP	I-NP	O
-RRB-	-RRB-	NNP	I-NP	O
to	to	TO	B-PP	O
SULFA	SULFA	NNP	B-NP	O
Reason	Reason	NNP	I-NP	O
for	for	IN	B-PP	O
override	override	NN	B-NP	O
:	:	:	O	O
tolerates	tolerate	VBZ	B-VP	O
Previous	Previous	NNP	B-NP	O
Alert	Alert	NNP	I-NP	O
overridden	overridden	JJ	I-NP	O
Override	Override	NNP	I-NP	O
added	add	VBD	B-VP	O
on	on	IN	B-PP	O
7/5	7/5	CD	B-NP	O
by	by	IN	B-PP	O
QUAIN	QUAIN	NNP	B-NP	B-protein
,	,	,	O	O
ETHAN	ETHAN	NNP	B-NP	O
CURT	CURT	NNP	I-NP	O
,	,	,	O	O
M.D.	M.D.	NNP	B-NP	O
POSSIBLE	POSSIBLE	NNP	I-NP	O
ALLERGY	ALLERGY	NNP	I-NP	O
-LRB-	-LRB-	NNP	I-NP	O
OR	OR	NNP	I-NP	O
SENSITIVITY	SENSITIVITY	NNP	I-NP	O
-RRB-	-RRB-	NNP	I-NP	O
to	to	TO	B-PP	O
SULFA	SULFA	NNP	B-NP	O
Reason	Reason	NNP	I-NP	O
for	for	IN	B-PP	O
override	override	NN	B-NP	O
:	:	:	O	O
tolerates	tolerate	VBZ	B-VP	O
MICRONASE	MICRONASE	NN	B-NP	B-protein
-LRB-	-LRB-	NN	I-NP	O
GLYBURIDE	GLYBURIDE	NN	I-NP	O
-RRB-	-RRB-	NN	I-NP	O
10	10	CD	I-NP	O
MG	MG	NNP	I-NP	O
PO	PO	NNP	I-NP	O
BID	BID	NNP	I-NP	O
Alert	Alert	NNP	I-NP	O
overridden	overridden	JJ	I-NP	O
:	:	:	O	O
Override	Override	NN	B-NP	O
added	add	VBN	B-VP	O
on	on	IN	B-PP	O
7/5	7/5	CD	B-NP	O
by	by	IN	B-PP	O
FARUG	FARUG	NNP	B-NP	O
,	,	,	O	O
CHAUNCEY	CHAUNCEY	NNP	B-NP	O
STANFORD	STANFORD	NNP	I-NP	O
,	,	,	O	O
M.D.	M.D.	NNP	B-NP	O
POSSIBLE	POSSIBLE	NNP	I-NP	O
ALLERGY	ALLERGY	NNP	I-NP	O
-LRB-	-LRB-	NNP	I-NP	O
OR	OR	NNP	I-NP	O
SENSITIVITY	SENSITIVITY	NNP	I-NP	O
-RRB-	-RRB-	NNP	I-NP	O
to	to	TO	B-PP	O
SULFA	SULFA	NNP	B-NP	O
Reason	Reason	NNP	I-NP	O
for	for	IN	B-PP	O
override	override	NN	B-NP	O
:	:	:	O	O
tolerates	tolerate	VBZ	B-VP	O
Previous	Previous	NNP	B-NP	O
Alert	Alert	NNP	I-NP	O
overridden	overridden	JJ	I-NP	O
Override	Override	NNP	I-NP	O
added	add	VBD	B-VP	O
on	on	IN	B-PP	O
7/5	7/5	CD	B-NP	O
by	by	IN	B-PP	O
GERETY	GERETY	NNP	B-NP	O
,	,	,	O	O
LINWOOD	LINWOOD	NNP	B-NP	O
KAREEM	KAREEM	NNP	I-NP	O
,	,	,	O	O
M.D.	M.D.	NNP	B-NP	O
POSSIBLE	POSSIBLE	NNP	I-NP	O
ALLERGY	ALLERGY	NNP	I-NP	O
-LRB-	-LRB-	NNP	I-NP	O
OR	OR	NNP	I-NP	O
SENSITIVITY	SENSITIVITY	NNP	I-NP	O
-RRB-	-RRB-	NNP	I-NP	O
to	to	TO	B-PP	O
SULFA	SULFA	NNP	B-NP	O
Reason	Reason	NNP	I-NP	O
for	for	IN	B-PP	O
override	override	NN	B-NP	O
:	:	:	O	O
tolerates	tolerate	VBZ	B-VP	O
Previous	Previous	NNP	B-NP	O
Alert	Alert	NNP	I-NP	O
overridden	overridden	JJ	I-NP	O
Override	Override	NNP	I-NP	O
added	add	VBD	B-VP	O
on	on	IN	B-PP	O
7/5	7/5	CD	B-NP	O
by	by	IN	B-PP	O
TESSITORE	TESSITORE	NN	B-NP	O
,	,	,	O	O
ALDEN	ALDEN	NNP	B-NP	O
GUY	GUY	NNP	I-NP	O
,	,	,	O	O
M.D.	M.D.	NNP	B-NP	O
POSSIBLE	POSSIBLE	NNP	I-NP	O
ALLERGY	ALLERGY	NNP	I-NP	O
-LRB-	-LRB-	NNP	I-NP	O
OR	OR	NNP	I-NP	O
SENSITIVITY	SENSITIVITY	NNP	I-NP	O
-RRB-	-RRB-	NNP	I-NP	O
to	to	TO	B-PP	O
SULFA	SULFA	NNP	B-NP	O
Reason	Reason	NNP	I-NP	O
for	for	IN	B-PP	O
override	override	NN	B-NP	O
:	:	:	O	O
tolerates	tolerate	VBZ	B-VP	O
PLAQUENIL	PLAQUENIL	NN	B-NP	B-protein
-LRB-	-LRB-	NN	I-NP	I-protein
HYDROXYCHLOROQUINE	HYDROXYCHLOROQUINE	NN	I-NP	I-protein
-RRB-	-RRB-	NN	I-NP	I-protein
200	200	CD	I-NP	I-protein
MG	MG	NNP	I-NP	I-protein
PO	PO	NNP	I-NP	I-protein
BID	BID	NNP	I-NP	O
Food/Drug	Food/Drug	NNP	I-NP	O
Interaction	Interaction	NNP	I-NP	O
Instruction	Instruction	NNP	I-NP	O
Give	Give	NNP	I-NP	O
with	with	IN	B-PP	O
meals	meal	NNS	B-NP	O
ISORDIL	ISORDIL	NNP	I-NP	O
-LRB-	-LRB-	NNP	I-NP	O
ISOSORBIDE	ISOSORBIDE	NNP	I-NP	O
DINITRATE	DINITRATE	NNP	I-NP	O
-RRB-	-RRB-	NNP	I-NP	O
40	40	CD	I-NP	O
MG	MG	NN	I-NP	O
PO	PO	NN	I-NP	O
TID	TID	NN	I-NP	O
HOLD	HOLD	NN	I-NP	O
IF	IF	NN	I-NP	O
:	:	:	O	O
sbp	sbp	NN	B-NP	O
<	<	SYM	O	O
90	90	CD	B-NP	O
LISINOPRIL	LISINOPRIL	NN	I-NP	O
20	20	CD	B-NP	O
MG	MG	NN	I-NP	O
PO	PO	NN	I-NP	O
BID	BID	NN	I-NP	O
HOLD	HOLD	NN	I-NP	O
IF	IF	NN	I-NP	O
:	:	:	O	O
sbp	sbp	NN	B-NP	O
<	<	SYM	O	O
100	100	CD	B-NP	O
Override	Override	NNP	I-NP	O
Notice	Notice	NNP	I-NP	O
:	:	:	O	O
Override	Override	NNP	B-NP	O
added	add	VBD	B-VP	O
on	on	IN	B-PP	O
7/5	7/5	CD	B-NP	O
by	by	IN	B-PP	O
SIWEK	SIWEK	NNP	B-NP	B-protein
,	,	,	O	O
ASHLEY	ASHLEY	NNP	B-NP	O
KENNITH	KENNITH	NNP	I-NP	O
,	,	,	O	O
M.D.	M.D.	NNP	B-NP	O
on	on	IN	B-PP	O
order	order	NN	B-NP	O
for	for	IN	B-PP	O
KCL	KCL	NNP	B-NP	O
IMMEDIATE	IMMEDIATE	NNP	I-NP	O
REL	REL	NNP	I-NP	O
.	.	.	O	O

PO	PO	NN	B-NP	O
SCALE	SCALE	NN	I-NP	O
QD	QD	NN	I-NP	O
-LRB-	-LRB-	NN	I-NP	O
ref	ref	NN	I-NP	O
#	#	#	B-NP	O
23409701	23409701	CD	I-NP	O
-RRB-	-RRB-	NNP	I-NP	O
POTENTIALLY	POTENTIALLY	NNP	I-NP	O
SERIOUS	SERIOUS	NNP	I-NP	O
INTERACTION	INTERACTION	NNP	I-NP	O
:	:	:	O	O
LISINOPRIL	LISINOPRIL	NNP	B-NP	O
&	&	CC	I-NP	O
POTASSIUM	POTASSIUM	NNP	I-NP	O
CHLORIDE	CHLORIDE	NNP	I-NP	O
Reason	Reason	NNP	I-NP	O
for	for	IN	B-PP	O
override	override	NN	B-NP	O
:	:	:	O	O
tolerates	tolerate	VBZ	B-VP	O
Previous	Previous	JJ	B-NP	O
override	override	NN	I-NP	O
information	information	NN	I-NP	O
:	:	:	O	O
Override	Override	NN	B-NP	O
added	add	VBN	B-VP	O
on	on	IN	B-PP	O
7/5	7/5	CD	B-NP	O
by	by	IN	B-PP	O
ALKIRE	ALKIRE	NN	B-NP	O
,	,	,	O	O
EUSEBIO	EUSEBIO	NNP	B-NP	O
LYLE	LYLE	NNP	I-NP	O
,	,	,	O	O
M.D.	M.D.	NNP	B-NP	O
POTENTIALLY	POTENTIALLY	NNP	I-NP	O
SERIOUS	SERIOUS	NNP	I-NP	O
INTERACTION	INTERACTION	NNP	I-NP	O
:	:	:	O	O
POTASSIUM	POTASSIUM	NNP	B-NP	O
CHLORIDE	CHLORIDE	NNP	I-NP	O
&	&	CC	I-NP	O
LISINOPRIL	LISINOPRIL	NNP	I-NP	O
Reason	Reason	NNP	I-NP	O
for	for	IN	B-PP	O
override	override	NN	B-NP	O
:	:	:	O	O
tolerates	tolerate	VBZ	B-VP	O
Previous	Previous	NNP	B-NP	O
Override	Override	NNP	I-NP	O
Notice	Notice	NNP	I-NP	O
Override	Override	NNP	I-NP	O
added	add	VBD	B-VP	O
on	on	IN	B-PP	O
7/5	7/5	CD	B-NP	O
by	by	IN	B-PP	O
KUPRES	KUPRES	NNP	B-NP	O
,	,	,	O	O
OSWALDO	OSWALDO	NNP	B-NP	O
DEVIN	DEVIN	NNP	I-NP	O
,	,	,	O	O
M.D.	M.D.	NNP	B-NP	O
on	on	IN	B-PP	O
order	order	NN	B-NP	O
for	for	IN	B-PP	O
KCL	KCL	NNP	B-NP	O
IMMEDIATE	IMMEDIATE	NNP	I-NP	O
REL	REL	NNP	I-NP	O
.	.	.	O	O

PO	PO	NN	B-NP	O
-LRB-	-LRB-	NN	I-NP	O
ref	ref	NN	I-NP	O
#	#	#	B-NP	O
23409701	23409701	CD	I-NP	O
-RRB-	-RRB-	NNP	I-NP	O
POTENTIALLY	POTENTIALLY	NNP	I-NP	O
SERIOUS	SERIOUS	NNP	I-NP	O
INTERACTION	INTERACTION	NNP	I-NP	O
:	:	:	O	O
LISINOPRIL	LISINOPRIL	NNP	B-NP	O
&	&	CC	I-NP	O
POTASSIUM	POTASSIUM	NNP	I-NP	O
CHLORIDE	CHLORIDE	NNP	I-NP	O
Reason	Reason	NNP	I-NP	O
for	for	IN	B-PP	O
override	override	NN	B-NP	O
:	:	:	O	O
monitored	monitor	VBN	B-VP	O
LOPRESSOR	LOPRESSOR	NNP	B-NP	O
-LRB-	-LRB-	NNP	I-NP	O
METOPROLOL	METOPROLOL	NNP	I-NP	O
TARTRATE	TARTRATE	NNP	I-NP	O
-RRB-	-RRB-	NNP	I-NP	O
25	25	CD	I-NP	O
MG	MG	NNP	I-NP	O
PO	PO	NNP	I-NP	O
BID	BID	NNP	I-NP	O
HOLD	HOLD	NN	I-NP	O
IF	IF	NN	I-NP	O
:	:	:	O	O
sbp	sbp	NN	B-NP	O
<	<	SYM	O	O
100	100	CD	B-NP	O
HR	HR	NN	I-NP	O
60	60	CD	B-NP	O
Food/Drug	Food/Drug	NN	I-NP	O
Interaction	Interaction	NN	I-NP	O
Instruction	Instruction	NN	I-NP	O
Take	Take	NN	I-NP	O
with	with	IN	B-PP	O
food	food	NN	B-NP	O
Alert	Alert	NNP	I-NP	O
overridden	overridden	JJ	I-NP	O
:	:	:	O	O
Override	Override	NN	B-NP	O
added	add	VBN	B-VP	O
on	on	IN	B-PP	O
7/5	7/5	CD	B-NP	O
by	by	IN	B-PP	O
SIEBERT	SIEBERT	NNP	B-NP	O
,	,	,	O	O
DOUGLAS	DOUGLAS	NNP	B-NP	O
GERALD	GERALD	NNP	I-NP	O
,	,	,	O	O
M.D.	M.D.	NNP	B-NP	O
DEFINITE	DEFINITE	NNP	I-NP	O
ALLERGY	ALLERGY	NNP	I-NP	O
-LRB-	-LRB-	NNP	I-NP	O
OR	OR	NNP	I-NP	O
SENSITIVITY	SENSITIVITY	NNP	I-NP	O
-RRB-	-RRB-	NNP	I-NP	O
to	to	TO	B-PP	O
BETA-BLOCKERS	BETA-BLOCKERS	NNP	B-NP	O
Reason	Reason	NNP	I-NP	O
for	for	IN	B-PP	O
override	override	NN	B-NP	O
:	:	:	O	O
tolerates	tolerate	VBZ	B-VP	O
Previous	Previous	NNP	B-NP	O
Alert	Alert	NNP	I-NP	O
overridden	overridden	JJ	I-NP	O
Override	Override	NNP	I-NP	O
added	add	VBD	B-VP	O
on	on	IN	B-PP	O
7/5	7/5	CD	B-NP	O
by	by	IN	B-PP	O
CENTANO	CENTANO	NNP	B-NP	O
,	,	,	O	O
LEVI	LEVI	NNP	B-NP	O
CLAUD	CLAUD	NNP	I-NP	O
,	,	,	O	O
M.D.	M.D.	NNP	B-NP	O
DEFINITE	DEFINITE	NNP	I-NP	O
ALLERGY	ALLERGY	NNP	I-NP	O
-LRB-	-LRB-	NNP	I-NP	O
OR	OR	NNP	I-NP	O
SENSITIVITY	SENSITIVITY	NNP	I-NP	O
-RRB-	-RRB-	NNP	I-NP	O
to	to	TO	B-PP	O
BETA-BLOCKERS	BETA-BLOCKERS	NNP	B-NP	O
Reason	Reason	NNP	I-NP	O
for	for	IN	B-PP	O
override	override	NN	B-NP	O
:	:	:	O	O
monitored	monitor	VBN	B-NP	O
NITROGLYCERIN	NITROGLYCERIN	NN	I-NP	B-protein
1/150	1/150	CD	I-NP	I-protein
-LRB-	-LRB-	HYPH	I-NP	I-protein
0.4	0.4	CD	I-NP	I-protein
MG	MG	NN	I-NP	I-protein
-RRB-	-RRB-	HYPH	B-NP	I-protein
1	1	CD	I-NP	I-protein
TAB	TAB	NN	I-NP	I-protein
SL	SL	NN	I-NP	I-protein
q5min	q5min	NN	I-NP	I-protein
x	x	SYM	B-NP	I-protein
3	3	CD	I-NP	I-protein
PRN	PRN	NN	I-NP	I-protein
chest	chest	NN	I-NP	I-protein
pain	pain	NN	I-NP	I-protein
HOLD	HOLD	NN	I-NP	I-protein
IF	IF	NN	I-NP	I-protein
:	:	:	O	O
SBP	SBP	NN	B-NP	B-protein
<	<	SYM	O	O
100	100	CD	B-NP	O
COUMADIN	COUMADIN	NN	I-NP	O
-LRB-	-LRB-	NN	I-NP	O
WARFARIN	WARFARIN	NN	I-NP	O
SODIUM	SODIUM	NN	I-NP	O
-RRB-	-RRB-	NN	I-NP	O
EVEN	EVEN	NN	I-NP	O
days	day	NNS	I-NP	O
:	:	:	O	O
5	5	CD	B-NP	O
MG	MG	NN	I-NP	O
qTTHSat	qTTHSat	NN	I-NP	O
;	;	:	O	O
ODD	ODD	NN	B-NP	O
days	day	NNS	I-NP	O
:	:	:	O	O
2.5	2.5	CD	B-NP	O
MG	MG	NN	I-NP	O
qMWF	qMWF	NN	I-NP	O
PO	PO	NNP	I-NP	O
QD	QD	NNP	I-NP	O
Starting	Starting	NNP	I-NP	O
Today	Today	NNP	I-NP	O
-LRB-	-LRB-	NNP	I-NP	O
8/3	8/3	CD	I-NP	O
-RRB-	-RRB-	HYPH	I-NP	O
HOLD	HOLD	NN	I-NP	B-protein
IF	IF	NN	I-NP	I-protein
:	:	:	O	O
INR	INR	NN	B-NP	B-protein
>	>	JJR	B-NP	O
3.0	3.0	CD	I-NP	O
and	and	CC	O	O
call	call	VB	B-VP	O
primary	primary	JJ	B-NP	O
doctor	doctor	NN	I-NP	O
Food/Drug	Food/Drug	NN	I-NP	O
Interaction	Interaction	NN	I-NP	O
Instruction	Instruction	NN	I-NP	O
No	No	DT	B-NP	O
high	high	JJ	I-NP	O
Vitamin-K	Vitamin-K	NN	I-NP	O
containing	contain	VBG	B-VP	O
foods	food	NNS	B-NP	O
Alert	Alert	NNP	B-NP	O
overridden	overridden	JJ	B-ADJP	O
:	:	:	O	O
Override	Override	NN	B-NP	O
added	add	VBN	B-VP	O
on	on	IN	B-PP	O
7/19	7/19	CD	B-NP	O
by	by	IN	B-PP	O
MCCLISH	MCCLISH	NN	B-NP	O
,	,	,	O	O
ZACK	ZACK	NNP	B-NP	O
R.	R.	NNP	I-NP	O
POTENTIALLY	POTENTIALLY	NNP	I-NP	O
SERIOUS	SERIOUS	NNP	I-NP	O
INTERACTION	INTERACTION	NNP	I-NP	O
:	:	:	O	O
AMIODARONE	AMIODARONE	NNP	B-NP	O
HCL	HCL	NNP	I-NP	O
&	&	CC	I-NP	O
WARFARIN	WARFARIN	NNP	I-NP	O
Reason	Reason	NNP	I-NP	O
for	for	IN	B-PP	O
override	override	NN	B-NP	O
:	:	:	O	O
md	md	NN	B-NP	O
aware	aware	JJ	I-NP	O
NORVASC	NORVASC	NNP	I-NP	O
-LRB-	-LRB-	NNP	I-NP	O
AMLODIPINE	AMLODIPINE	NNP	I-NP	O
-RRB-	-RRB-	NNP	I-NP	O
10	10	CD	I-NP	O
MG	MG	NN	I-NP	O
PO	PO	NN	I-NP	O
QD	QD	NN	I-NP	O
HOLD	HOLD	NN	I-NP	O
IF	IF	NN	I-NP	O
:	:	:	O	O
sbp	sbp	NN	B-NP	O
<	<	SYM	O	O
100	100	CD	B-NP	O
LOVENOX	LOVENOX	NN	I-NP	O
-LRB-	-LRB-	HYPH	B-NP	O
ENOXAPARIN	ENOXAPARIN	NN	I-NP	B-protein
-RRB-	-RRB-	HYPH	B-NP	O
70	70	CD	I-NP	O
MG	MG	NN	I-NP	O
SC	SC	NN	I-NP	O
Q12H	Q12H	NN	I-NP	O
X	X	NN	I-NP	O
4	4	CD	I-NP	O
Days	Days	NNP	I-NP	O
Starting	Starting	NNP	I-NP	O
Today	Today	NNP	I-NP	O
-LRB-	-LRB-	NNP	I-NP	O
8/3	8/3	CD	I-NP	O
-RRB-	-RRB-	HYPH	I-NP	O
HOLD	HOLD	NN	I-NP	O
IF	IF	NN	I-NP	O
:	:	:	O	O
INR	INR	NN	B-NP	B-protein
is	be	VBZ	B-VP	O
2-3	2-3	CD	B-NP	O
Instructions	Instruction	NNPS	I-NP	O
:	:	:	O	O
Please	Please	NN	B-NP	B-protein
give	give	VB	B-VP	O
first	first	JJ	B-NP	O
dose	dose	NN	I-NP	O
today	today	NN	B-NP	O
and	and	CC	O	O
provide	provide	VB	B-VP	O
teaching	teaching	NN	B-NP	O
.	.	.	O	O

Would	Would	MD	B-VP	O
have	have	VB	I-VP	O
her	her	PRP$	B-NP	O
visiting	visit	VBG	I-NP	O
nurse	nurse	NN	I-NP	O
give	give	VBP	B-VP	O
the	the	DT	B-NP	O
injections	injection	NNS	I-NP	O
if	if	IN	B-SBAR	O
INR	INR	NN	B-NP	B-protein
is	be	VBZ	B-VP	O
not	not	RB	O	O
2-3	2-3	CD	B-NP	O
DIET	DIET	NN	I-NP	O
:	:	:	O	O
No	No	DT	B-NP	O
Restrictions	Restriction	NNS	I-NP	O
RETURN	RETURN	NNP	B-NP	O
TO	TO	NNP	I-NP	O
WORK	WORK	NNP	I-NP	O
:	:	:	O	O
Not	Not	NNP	B-NP	O
Applicable	Applicable	NNP	I-NP	O
FOLLOW	FOLLOW	NNP	I-NP	O
UP	UP	NNP	I-NP	O
APPOINTMENT	APPOINTMENT	NNP	I-NP	O
-LRB-	-LRB-	NNP	I-NP	O
S	S	NNP	I-NP	O
-RRB-	-RRB-	NNP	I-NP	O
:	:	:	O	O
Dr.	Dr.	NNP	B-NP	O
Wilber	Wilber	NNP	I-NP	O
Tussing	Tussing	NNP	I-NP	O
1-2	1-2	NN	I-NP	O
weeks	week	NNS	I-NP	O
,	,	,	O	O
patient	patient	NN	B-NP	O
to	to	TO	B-VP	O
call	call	VB	I-VP	O
for	for	IN	B-PP	O
an	an	DT	B-NP	O
appointment	appointment	NN	I-NP	O
,	,	,	O	O
Dr.	Dr.	NNP	B-NP	O
Heriberto	Heriberto	NNP	I-NP	O
Mertins	Mertins	NNP	I-NP	O
,	,	,	O	O
Cardiology	Cardiology	NNP	B-NP	O
2-3	2-3	CD	I-NP	O
weeks	week	NNS	I-NP	O
,	,	,	O	O
patient	patient	NN	B-NP	O
to	to	TO	B-VP	O
call	call	VB	I-VP	O
for	for	IN	B-PP	O
appointment	appointment	NN	B-NP	O
,	,	,	O	O
ALLERGY	ALLERGY	NN	B-NP	O
:	:	:	O	O
Sotalol	Sotalol	NN	B-NP	O
,	,	,	O	O
Procainamide	Procainamide	NNP	B-NP	O
,	,	,	O	O
Aspirin	Aspirin	NNP	B-NP	O
,	,	,	O	O
Penicillins	Penicillins	NNP	B-NP	O
,	,	,	O	O
Sulfa	Sulfa	NNP	B-NP	O
,	,	,	O	O
Quinaglute	Quinaglute	NNP	B-NP	O
,	,	,	O	O
Asa	Asa	NNP	B-NP	O
ADMIT	ADMIT	NNP	I-NP	O
DIAGNOSIS	DIAGNOSIS	NNP	I-NP	O
:	:	:	O	O
Syncope	Syncope	NNP	B-NP	O
,	,	,	O	O
R/O	R/O	NNP	B-NP	O
MI	MI	NNP	I-NP	O
PRINCIPAL	PRINCIPAL	NNP	I-NP	O
DISCHARGE	DISCHARGE	NNP	I-NP	O
DIAGNOSIS	DIAGNOSIS	NNP	I-NP	O
;	;	:	O	O
Responsible	Responsible	JJ	B-ADJP	O
After	After	IN	B-PP	O
Study	Study	NNP	B-NP	O
for	for	IN	B-PP	O
Causing	Causing	NNP	B-NP	O
Admission	Admission	NNP	I-NP	O
-RRB-	-RRB-	NNP	I-NP	O
Syncope	Syncope	NNP	I-NP	O
OTHER	OTHER	NNP	I-NP	O
DIAGNOSIS	DIAGNOSIS	NNP	I-NP	O
;	;	:	O	O
Conditions	Condition	NNS	B-NP	O
,	,	,	O	O
Infections	Infection	NNS	B-NP	O
,	,	,	O	O
Complications	Complication	NNS	B-NP	O
,	,	,	O	O
affecting	affect	VBG	B-VP	O
Treatment/Stay	Treatment/Stay	NNP	B-NP	O
OPERATIONS	OPERATIONS	NNPS	I-NP	O
AND	AND	CC	I-NP	O
PROCEDURES	PROCEDURES	NNPS	I-NP	O
:	:	:	O	O
OTHER	OTHER	NN	B-NP	O
TREATMENTS/PROCEDURES	TREATMENTS/PROCEDURES	VBZ	B-VP	O
-LRB-	-LRB-	NNP	B-NP	O
NOT	NOT	NNP	I-NP	O
IN	IN	NNP	I-NP	O
O.R.	O.R.	NNP	I-NP	O
-RRB-	-RRB-	NNP	I-NP	O
BRIEF	BRIEF	NNP	I-NP	O
RESUME	RESUME	NNP	I-NP	O
OF	OF	IN	B-PP	O
HOSPITAL	HOSPITAL	NNP	B-NP	O
COURSE	COURSE	NN	I-NP	O
:	:	:	O	O
***	***	SYM	B-NP	O
7/19	7/19	CD	I-NP	O
***	***	SYM	I-NP	O
7/9	7/9	CD	I-NP	O
78F	78F	NN	I-NP	O
w	w	NN	I-NP	O
/	/	SYM	B-VP	O
HTN	HTN	NN	B-NP	B-protein
,	,	,	O	O
PAFon	PAFon	NN	B-NP	O
amiodarone	amiodarone	NN	I-NP	O
,	,	,	O	O
MS	MS	NN	B-NP	B-protein
s/p	s/p	NN	I-NP	I-protein
MVR	MVR	NN	I-NP	I-protein
on	on	IN	B-PP	O
coumadin	coumadin	NN	B-NP	O
,	,	,	O	O
?	?	.	O	O

CAD/IMI	CAD/IMI	NN	B-NP	O
with	with	IN	B-PP	O
clean	clean	JJ	B-NP	O
coronaries	coronary	NNS	I-NP	O
on	on	IN	B-PP	O
cath	cath	NN	B-NP	B-protein
'91	'91	CD	I-NP	I-protein
,	,	,	O	O
h/o	h/o	NN	B-NP	B-protein
CHF	CHF	NN	I-NP	I-protein
,	,	,	O	O
now	now	RB	B-ADVP	O
presenting	present	VBG	B-VP	O
with	with	IN	B-PP	O
2	2	CD	B-NP	O
episodes	episode	NNS	I-NP	O
of	of	IN	B-PP	O
?	?	.	O	O

syncope	syncope	NN	B-NP	O
.	.	.	O	O

First	First	JJ	B-NP	O
episode	episode	NN	I-NP	O
while	while	IN	B-SBAR	O
sitting	sit	VBG	B-VP	O
,	,	,	O	O
?	?	.	O	O

LOC	LOC	NN	B-NP	O
,	,	,	O	O
second	second	JJ	B-NP	O
episode	episode	NN	I-NP	O
while	while	IN	B-SBAR	O
leaning	lean	VBG	B-VP	O
over	over	RB	B-PRT	O
,	,	,	O	O
likely	likely	RB	B-NP	O
no	no	DT	I-NP	O
LOC	LOC	NN	I-NP	O
,	,	,	O	O
both	both	DT	B-NP	O
episodes	episode	NNS	I-NP	O
without	without	IN	B-PP	O
pre	pre	AFX	B-NP	B-DNA
-	-	HYPH	I-NP	O
or	or	CC	I-NP	O
post-syncopal	post-syncopal	JJ	I-NP	O
SOB/palpitations/lightheadedness	SOB/palpitations/lightheadedness	NN	I-NP	O
/	/	SYM	B-NP	O
confusion	confusion	NN	B-NP	O
or	or	CC	O	O
other	other	JJ	B-NP	O
sx	sx	NN	I-NP	O
.	.	.	O	O

In	In	IN	B-PP	O
ED	ED	NN	B-NP	O
had	have	VBD	B-VP	O
Lleg/armpain	Lleg/armpain	NN	B-NP	O
and	and	CC	I-NP	O
HA	HA	NN	I-NP	O
.	.	.	O	O

Had	Have	VBD	B-VP	O
negative	negative	JJ	B-NP	O
Head	Head	NNP	I-NP	O
CT	CT	NN	I-NP	O
,	,	,	O	O
neg	neg	NN	B-NP	O
Lextremity	Lextremity	NNP	I-NP	O
films	film	NNS	I-NP	O
.	.	.	O	O

Meds	Med	NNS	B-NP	O
noteable	noteable	JJ	B-ADJP	O
for	for	IN	B-PP	O
extensive	extensive	JJ	B-NP	O
cardiac	cardiac	JJ	I-NP	O
regimen	regimen	NN	I-NP	O
including	include	VBG	B-PP	O
lopressor	lopressor	NN	B-NP	O
,	,	,	O	O
coumadin	coumadin	NN	B-NP	O
,	,	,	O	O
amio	amio	NN	B-NP	O
,	,	,	O	O
norvasc	norvasc	NN	B-NP	O
,	,	,	O	O
lisinopril	lisinopril	NN	B-NP	O
,	,	,	O	O
lasix	lasix	NN	B-NP	O
,	,	,	O	O
isordil	isordil	NN	B-NP	O
.	.	.	O	O

CXR	CXR	NN	B-NP	B-protein
showed	show	VBD	B-VP	O
mild	mild	JJ	B-NP	O
CHF	CHF	NN	I-NP	O
?	?	.	O	O

Lbase	Lbase	NN	B-NP	O
effusion	effusion	NN	I-NP	O
.	.	.	O	O

ECHO	ECHO	NN	B-NP	O
18	18	CD	I-NP	O
of	of	IN	B-PP	O
January	January	NNP	B-NP	O
EF65	EF65	NNP	I-NP	O
%	%	NN	I-NP	O
,	,	,	O	O
EKG	EKG	NN	B-NP	O
old	old	JJ	I-NP	O
inferior	inferior	JJ	I-NP	O
MI	MI	NN	I-NP	O
changes/primary	changes/primary	JJ	I-NP	O
AVblock	AVblock	NN	I-NP	O
.	.	.	O	O

Noted	Note	VBN	B-NP	O
bradycardia	bradycardia	NN	I-NP	O
to	to	TO	B-PP	O
30s	30s	CD	B-NP	O
while	while	IN	B-SBAR	O
asleep	asleep	NN	B-NP	O
on	on	IN	B-PP	O
night	night	NN	B-NP	O
of	of	IN	B-PP	O
admission	admission	NN	B-NP	O
CV	CV	NN	I-NP	O
:	:	:	O	O
unclear	unclear	JJ	B-NP	O
etiology	etiology	NN	I-NP	O
of	of	IN	B-PP	O
syncopal	syncopal	JJ	B-NP	O
episodes	episode	NNS	I-NP	O
but	but	CC	O	O
CV	CV	NN	B-NP	O
likely	likely	RB	B-VP	O
given	give	VBN	I-VP	O
her	her	PRP$	B-NP	O
history	history	NN	I-NP	O
.	.	.	O	O

Will	Will	MD	B-VP	O
call	call	VB	I-VP	O
Cards	Cards	NNP	B-NP	O
consult	consult	NN	I-NP	O
in	in	IN	B-PP	O
a.m.	a.m.	RB	B-NP	O
Important	Important	JJ	I-NP	O
to	to	TO	B-VP	O
assess	assess	VB	I-VP	O
specific	specific	JJ	B-NP	O
etiology	etiology	NN	I-NP	O
given	give	VBN	B-VP	O
need	need	NN	B-NP	O
for	for	IN	B-PP	O
coumadin	coumadin	NN	B-NP	O
for	for	IN	B-PP	O
MVR	MVR	NN	B-NP	B-protein
versus	versus	CC	I-NP	O
fall	fall	NN	I-NP	O
risk	risk	NN	I-NP	O
with	with	IN	B-PP	O
the	the	DT	B-NP	O
syncopal	syncopal	JJ	I-NP	O
episodes.Orthostatics	episodes.Orthostatics	NN	I-NP	O
negative	negative	JJ	B-ADJP	O
.	.	.	O	O

Cardiology	Cardiology	NNP	B-NP	O
consulted	consult	VBD	B-VP	O
,	,	,	O	O
and	and	CC	O	O
recommended	recommend	VBD	B-VP	O
an	an	DT	B-NP	O
event	event	NN	I-NP	O
monitor	monitor	NN	I-NP	O
to	to	TO	B-VP	O
assess	assess	VB	I-VP	O
for	for	IN	B-PP	O
specific	specific	JJ	B-NP	O
rhythms	rhythm	NNS	I-NP	O
while	while	IN	B-SBAR	O
she	she	PRP	B-NP	O
is	be	VBZ	B-VP	O
symptomatic	symptomatic	JJ	B-ADJP	O
.	.	.	O	O

Over	Over	IN	B-PP	O
her	her	PRP$	B-NP	O
hospital	hospital	NN	I-NP	O
course	course	NN	I-NP	O
,	,	,	O	O
she	she	PRP	B-NP	O
had	have	VBD	B-VP	O
one	one	CD	B-NP	O
episode	episode	NN	I-NP	O
of	of	IN	B-PP	O
near-syncope	near-syncope	NN	B-NP	O
similar	similar	JJ	B-ADJP	O
to	to	TO	B-PP	O
her	her	PRP$	B-NP	O
weekend	weekend	NN	I-NP	O
symptoms	symptom	NNS	I-NP	O
.	.	.	O	O

There	There	EX	B-NP	O
was	be	VBD	B-VP	O
no	no	DT	B-NP	O
typical	typical	JJ	I-NP	O
rhythm	rhythm	NN	I-NP	O
noted	note	VBN	B-VP	O
on	on	IN	B-PP	O
telemetry	telemetry	NN	B-NP	O
at	at	IN	B-PP	O
that	that	DT	B-NP	O
time	time	NN	I-NP	O
.	.	.	O	O

Cardiology	Cardiology	NNP	B-NP	O
recommended	recommend	VBD	B-VP	O
monitoring	monitor	VBG	I-VP	O
HR	HR	NN	B-NP	O
and	and	CC	I-NP	O
BP	BP	NN	I-NP	O
and	and	CC	O	O
consider	consider	VB	B-VP	O
d/c	d/c	NN	B-NP	O
`	`	``	O	O
ing	ing	VBG	B-VP	O
Lopressor	Lopressor	NN	B-NP	O
if	if	IN	B-SBAR	O
it	it	PRP	B-NP	O
is	be	VBZ	B-VP	O
excessively	excessively	RB	B-ADJP	O
low	low	JJ	I-ADJP	O
and	and	CC	O	O
correlating	correlate	VBG	B-VP	O
with	with	IN	B-PP	O
symptoms	symptom	NNS	B-NP	O
.	.	.	O	O

Would	Would	MD	B-VP	O
follow	follow	VB	I-VP	O
up	up	RP	B-PRT	O
on	on	IN	B-PP	O
event	event	NN	B-NP	O
monitor	monitor	NN	I-NP	O
to	to	TO	B-VP	O
determine	determine	VB	I-VP	O
need	need	NN	B-NP	O
for	for	IN	B-PP	O
further	further	JJ	B-NP	O
intervention	intervention	NN	I-NP	O
.	.	.	O	O

Neuro	Neuro	NNP	B-NP	O
:	:	:	O	O
Head	Head	JJ	B-NP	O
MR	MR	NN	I-NP	O
negative	negative	JJ	B-ADJP	O
;	;	:	O	O
ruled	rule	VBD	B-VP	O
out	out	RP	B-PRT	O
intracranial	intracranial	JJ	B-NP	O
ischemia/bleed	ischemia/bleed	NN	I-NP	O
.	.	.	O	O

Heme	Heme	NN	B-NP	B-protein
:	:	:	O	O
INR	INR	NN	B-NP	O
4.3	4.3	CD	I-NP	O
on	on	IN	B-PP	O
admission	admission	NN	B-NP	O
and	and	CC	O	O
restarted	restart	VBD	B-VP	O
after	after	IN	B-PP	O
holding	hold	VBG	B-VP	O
for	for	IN	B-PP	O
one	one	CD	B-NP	O
day	day	NN	I-NP	O
.	.	.	O	O

Restarted	Restart	VBN	B-NP	O
coumadin	coumadin	NN	I-NP	O
at	at	IN	B-PP	O
usual	usual	JJ	B-NP	O
home	home	NN	I-NP	O
dosing	dosing	NN	I-NP	O
.	.	.	O	O

On	On	IN	B-PP	O
7/10	7/10	CD	B-NP	O
INR	INR	NN	I-NP	O
was	be	VBD	B-VP	O
2.1	2.1	CD	B-NP	O
so	so	RB	B-VP	O
arranged	arrange	VBN	I-VP	O
for	for	IN	B-PP	O
4days	4day	NNS	B-NP	O
of	of	IN	B-PP	O
Lovenox	Lovenox	NNP	B-NP	O
to	to	TO	B-VP	O
be	be	VB	I-VP	O
given	give	VBN	I-VP	O
if	if	IN	B-SBAR	O
INR	INR	NN	B-NP	B-protein
is	be	VBZ	B-VP	O
not	not	RB	O	O
therapeutic	therapeutic	JJ	B-ADJP	O
.	.	.	O	O

Follow	Follow	VB	B-VP	O
up	up	RP	B-PRT	O
plan	plan	NN	B-NP	O
:	:	:	O	O
Event	Event	JJ	B-NP	O
monitor	monitor	NN	I-NP	O
to	to	TO	B-VP	O
be	be	VB	I-VP	O
ordered	order	VBN	I-VP	O
.	.	.	O	O

Patient	Patient	NN	B-NP	O
to	to	TO	B-VP	O
follow	follow	VB	I-VP	O
up	up	RP	B-PRT	O
with	with	IN	B-PP	O
Dr.	Dr.	NNP	B-NP	O
Bergerson	Bergerson	NNP	I-NP	O
and	and	CC	O	O
Dr.	Dr.	NNP	B-NP	O
Gamma	Gamma	NNP	I-NP	O
in	in	IN	B-PP	O
1-2	1-2	CD	B-NP	O
weeks	week	NNS	I-NP	O
.	.	.	O	O

Visiting	Visit	VBG	B-VP	O
nurse	nurse	NN	B-NP	O
to	to	TO	B-VP	O
do	do	VB	I-VP	O
home	home	NN	B-NP	O
safety	safety	NN	I-NP	O
eval	eval	NN	I-NP	O
,	,	,	O	O
and	and	CC	O	O
monitor	monitor	NN	B-NP	O
INR/administer	INR/administer	NNP	I-NP	O
Lovenox	Lovenox	NNP	I-NP	O
if	if	IN	B-SBAR	O
needed	need	VBN	B-VP	O
,	,	,	O	O
and	and	CC	O	O
check	check	NN	B-NP	O
BP/HR/symptoms	BP/HR/symptom	NNS	I-NP	O
.	.	.	O	O

ADDITIONAL	ADDITIONAL	JJ	B-NP	O
COMMENTS	COMMENTS	NNS	I-NP	O
:	:	:	O	O
For	For	IN	B-PP	O
visiting	visit	VBG	B-VP	O
nurse	nurse	NN	B-NP	O
:	:	:	O	O
Please	Please	NN	B-NP	O
draw	draw	NN	I-NP	O
blood	blood	NN	I-NP	O
qd	qd	NN	I-NP	O
for	for	IN	B-PP	O
5	5	CD	B-NP	O
days	day	NNS	I-NP	O
to	to	TO	B-VP	O
check	check	VB	I-VP	O
INR	INR	NN	B-NP	B-protein
.	.	.	O	O

If	If	IN	B-SBAR	O
it	it	PRP	B-NP	O
is	be	VBZ	B-VP	O
less	less	JJR	B-NP	O
than	than	IN	I-NP	O
2	2	CD	I-NP	O
please	please	NN	I-NP	O
give	give	VBP	B-VP	O
the	the	DT	B-NP	O
Lovenox	Lovenox	NNP	I-NP	O
injections	injection	NNS	I-NP	O
for	for	IN	B-PP	O
the	the	DT	B-NP	O
day	day	NN	I-NP	O
.	.	.	O	O

If	If	IN	B-SBAR	O
it	it	PRP	B-NP	O
remains	remain	VBZ	B-VP	O
in	in	IN	B-PP	O
2-3	2-3	NN	B-NP	O
range	range	NN	I-NP	O
,	,	,	O	O
just	just	RB	B-ADVP	O
continue	continue	VBP	B-VP	O
the	the	DT	B-NP	O
regular	regular	JJ	I-NP	O
Coumadin	Coumadin	NN	I-NP	O
dosing	dosing	NN	I-NP	O
.	.	.	O	O

Please	Please	NN	B-NP	B-protein
check	check	NN	I-NP	I-protein
BP	BP	NN	I-NP	I-protein
and	and	CC	I-NP	O
heart	heart	NN	I-NP	O
rate	rate	NN	I-NP	O
and	and	CC	O	O
call	call	VB	B-VP	O
primary	primary	JJ	B-NP	O
doctor	doctor	NN	I-NP	O
Dr.	Dr.	NNP	I-NP	O
Mickles	Mickles	NNP	I-NP	O
if	if	IN	B-SBAR	O
it	it	PRP	B-NP	O
is	be	VBZ	B-VP	O
excessively	excessively	RB	B-ADJP	O
low	low	JJ	I-ADJP	O
or	or	CC	I-ADJP	O
high	high	JJ	I-ADJP	O
and	and	CC	O	O
patient	patient	NN	B-NP	O
is	be	VBZ	B-VP	O
complaining	complain	VBG	I-VP	O
of	of	IN	B-PP	O
symptoms	symptom	NNS	B-NP	O
.	.	.	O	O

Please	Please	VB	B-VP	O
ensure	ensure	VB	I-VP	O
she	she	PRP	B-NP	O
is	be	VBZ	B-VP	O
wearing	wear	VBG	I-VP	O
her	her	PRP$	B-NP	O
event	event	NN	I-NP	O
monitor	monitor	NN	I-NP	O
.	.	.	O	O

DISCHARGE	DISCHARGE	NN	B-NP	O
CONDITION	CONDITION	NN	I-NP	O
:	:	:	O	O
Stable	Stable	JJ	B-NP	O
TO	TO	NN	I-NP	O
DO/PLAN	DO/PLAN	NN	I-NP	O
:	:	:	O	O
No	No	DT	B-NP	O
dictated	dictated	JJ	I-NP	O
summary	summary	NN	I-NP	O
ENTERED	ENTERED	NNP	I-NP	O
BY	BY	NNP	I-NP	O
:	:	:	O	O
DRIEVER	DRIEVER	NNP	B-NP	O
,	,	,	O	O
LOGAN	LOGAN	NNP	B-NP	O
W.	W.	NNP	I-NP	O
,	,	,	O	O
M.D.	M.D.	NNP	B-NP	O
-LRB-	-LRB-	NNP	I-NP	O
YX81	YX81	NNP	I-NP	O
-RRB-	-RRB-	NNP	I-NP	O
8/11	8/11	CD	I-NP	O
@	@	SYM	B-NP	O
01	01	CD	I-NP	O
******	******	SYM	I-NP	O
END	END	NN	I-NP	O
OF	OF	IN	B-PP	O
DISCHARGE	DISCHARGE	NN	B-NP	O
ORDERS	ORDERS	NNS	I-NP	O
******	******	SYM	B-NP	O

